Lessons Learned from the Pandemic: What Might the Future Bring? Workshop Session Eight

Since the pandemic began, biopharmaceutical companies have been partnering with government and
regulatory agencies to expedite a new generation of therapeutic and vaccine approaches. These
partnerships have shed a new light on novel CMC approaches that have accelerated manufacturing and
testing. In this session, panelists from around the world including representatives from government
agencies and industry will share their experiences with how accelerated CMC approaches enabled rapid
progression through development and how these experiences might be applied to future pandemics.